Optically transparent silk hydrogels

US12049481B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-12049481-B2
Application numberUS-202016872679-A
CountryUS
Kind codeB2
Filing dateMay 12, 2020
Priority dateSep 27, 2013
Publication dateJul 30, 2024
Grant dateJul 30, 2024

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The present application relates to silk fibroin-based hydrogels, methods for making and using the same.

First claim

Opening claim text (preview).

What is claimed is: 1. A composition comprising: a plurality of crystalized silk fibroin spheres, wherein the crystalized silk fibroin spheres have a diameter between about 10 nm and about 150 nm, the plurality of crystalized silk fibroin spheres arranged together to form a freestanding hydrogel structure having at least 60% optical transmittance in the visible spectrum. 2. The composition of claim 1 , the freestanding hydrogel structure having at least 95% transmittance in the visible spectrum. 3. The composition of claim 1 , the freestanding hydrogel structure having a compressive modulus between about 2 kPa and about 20 kPa when measured with a crosshead speed of about 2.0 mm/hr. 4. The composition of claim 1 , wherein the silk fibroin within the silk fibroin spheres is crosslinked. 5. The composition of claim 4 , wherein the silk fibroin is crosslinked with a crosslinking agent. 6. The composition of claim 5 , wherein the crosslinking agent is an amine-to-amine crosslinker, amine-to-sulfhydryl crosslinker, carboxyl-to-amine crosslinker, photoreactive crosslinker, sulfhydryl-to-carbohydrate crosslinker, sulfhydryl-to-hydroxyl crosslinker, sulfhydryl-to-sulfhydryl crosslinker, or any combination thereof. 7. The composition of claim 5 , wherein the crosslinking agent is EDTA. 8. A composition comprising: nanosized crystalline particles comprising silk fibroin polypeptides having an average molecular weight falling within the range of about 3.5 kDa to about 120 kDa, the nanosized crystalline particles having a diameter between about 10 nm and about 150 nm, and the nanosized crystalline particles arranged together to form a freestanding hydrogel structure having at least 60% optical transmittance in the visible spectrum. 9. The composition of claim 8 , the silk fibroin polypeptides having an average molecular weight falling within the range of about 25 kDa to about 120 kDa. 10. The composition of claim 8 , the silk fibroin polypeptides having an average molecular weight falling within the range of about 75 kDa to about 120 kDa. 11. The composition of claim 8 , wherein the freestanding hydrogel structure has at least one dimension that is at least 10 micrometers. 12. The composition of claim 8 , the freestanding hydrogel structure having a compressive modulus between about 2 kPa and about 20 kPa when measured with a crosshead speed of about 2.0 mm/hr. 13. The composition of claim 8 , the freestanding hydrogel structure comprising a predetermined microstructure fabricated therein. 14. The composition of claim 13 , wherein the predetermined microstructure is a void. 15. A composition comprising: a plurality of silk fibroin nanoparticles having a diameter between about 10 nm and about 150 nm, the plurality of silk fibroin nanoparticles arranged together to form a freestanding hydrogel structure. 16. The composition of claim 15 , wherein the plurality of silk fibroin nanoparticles are crosslinked by an amine-to-amine crosslinker, amine-to-sulfhydryl crosslinker, carboxyl-to-amine crosslinker, photoreactive crosslinker, sulfhydryl-to-carbohydrate crosslinker, sulfhydryl-to-hydroxyl crosslinker, sulfhydryl-to-sulfhydryl crosslinker, or any combination thereof. 17. The composition of claim 15 , the plurality of silk fibroin nanoparticles having a diameter between about 50 nm and about 150 nm. 18. The composition of claim 15 , the plurality of silk fibroin nanoparticles having a diameter between about 80 nm and about 120 nm. 19. The composition of claim 15 , the freestanding hydrogel structure having at least 60% transmittance in the visible spectrum. 20. The composition of claim 15 , the plurality of silk fibroin nanoparticles having a porosity between about 0% and about 50%.

Assignees

Inventors

Classifications

  • Cross-linking · CPC title

  • Substrates of biological origin, e.g. extracellular matrix, decellularised tissue · CPC title

  • Proteins · CPC title

  • General culture methods using substrates (for specific animal cell type C12N5/06) · CPC title

  • involving non-metallic material, e.g. isolators · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US12049481B2 cover?
The present application relates to silk fibroin-based hydrogels, methods for making and using the same.
Who is the assignee on this patent?
Univ Tufts
What technology area does this patent fall under?
Primary CPC classification A61K9/06. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Jul 30 2024 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).